Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 2/2014

01-02-2014 | Capsule Commentary

Capsule Commentary on Patrick et al., Trends in Insulin Initiation and Treatment Intensification among Patients with Type 2 Diabetes

Author: François R. Jornayvaz, M.D.

Published in: Journal of General Internal Medicine | Issue 2/2014

Login to get access

Excerpt

This study by Patrick et al.1 investigated the pattern of insulin initiation, as well as treatment intensification, among patients with type 2 diabetes compared to American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) guidelines. Although this observational study may not be representative of the general population, as the 7,932 studied patients were derived from a single commercial insurance company from a single state, the reported data are relevant to the treatment of type 2 diabetes for both primary care physicians and specialists. …
Literature
1.
Patrick AR, Fischer MA, Choudhry NK, Shrank WH, Seeger JD, Liu J, et al. Trends in insulin initiation and treatment intensification among patients with type 2 diabetes. J Gen Intern Med. doi:10.​1007/​s11606-013-2643-6.
2.
3.
4.
Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care. 2005;28(3):600–6.PubMedCrossRef
5.
Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–79. doi:10.​2337/​dc12-0413.PubMedCrossRef
Metadata
Title
Capsule Commentary on Patrick et al., Trends in Insulin Initiation and Treatment Intensification among Patients with Type 2 Diabetes
Author
François R. Jornayvaz, M.D.
Publication date
01-02-2014
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2676-x

Other articles of this Issue 2/2014

Journal of General Internal Medicine 2/2014 Go to the issue

Reply Letter

Marijuana Use and Health in Primary Care

Letter to the Editor

Routine Screening for Intimate Partner Violence in VHA: A Timely Opportunity

Original Research

Challenges Faced by Patients with Low Socioeconomic Status During the Post-Hospital Transition

Letter to the Editor

Marijuana Use and Health in Primary Care

Editorial

Nontraditional Risk Factors as Mediators of Racial Differences in Diabetes Risk

Original Research

The Influence of Community and Individual Health Literacy on Self-Reported Health Status
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits